Clinical inquiries. How should you manage an overweight breastfed infant?

Amimi Osayande1, Ricky Watson, Kathryn M Kolasa

  • 1Department of Family Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

Insights

Monitor exclusively breastfed infant growth using World Health Organization (WHO) curves. Reassure parents about healthy weight gain, advise on feeding behaviors, and seek specialist consultation for rare overgrowth concerns.

Area of Science:

  • Pediatrics
  • Infant Nutrition
  • Growth Monitoring

Background:

  • Assessing infant growth is crucial for identifying potential health issues.
  • Distinguishing normal variations in exclusively breastfed infants from pathological conditions can be challenging for parents and clinicians.

Purpose of the Study:

  • To provide guidance on monitoring and managing the growth of exclusively breastfed infants.
  • To differentiate normal, healthy weight gain from potential overgrowth syndromes.

Main Methods:

  • Utilizing World Health Organization (WHO) growth curves for plotting infant weight and length.
  • Clinical assessment of infant feeding behaviors, satiety, and physical activity.
  • Referral to lactation consultants, endocrinology, and genetics specialists when indicated.

Main Results:

  • Higher-than-normal weight gain in well-breastfeeding infants without supplementation is generally not associated with adverse effects.
  • Behavioral modifications for overfeeding or insufficient activity are recommended.
  • Specialist consultation is advised for rare cases of infants with lack of satiety or dysmorphia, suggesting overgrowth syndromes.

Conclusions:

  • Routine monitoring on WHO growth curves aids in assessing infant growth.
  • Parental reassurance and behavioral advice are key for managing healthy weight gain in breastfed infants.
  • Early identification and specialist referral are essential for rare overgrowth syndromes.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...